Site is Being Upgraded

Combinatorial therapy for Deafness: A therapeutic mix encompassing Spermidine, Cholecalciferol, Ajoene and DIM (SCAD) increases the expression of ATG5 (Autophagy-related 5), prevents aggregation of proteins in inclusion bodies, inhibits hair cell degeneration,  improves hearing loss via up regulation of its target genes, 28/February/2018, 11.55 pm

Molecular therapy for TIIDM and Metabolic defects: Syringic acid increases Sirtuin-4 expression, augments insulin secretion, reduces metabolic stress, improves glucose uptake, promotes glucose homeostasis and prevents progression to TIIDM via down regulation of its target gene, 28/November/2017, 11.43 pm
February 28, 2018
Activation of the PD-1 pathway for Pain therapy: DADLE ([D-Ala2, D-Leu5]-Enkephalin), a synthetic opioid peptide, increases the expression of PD-L1, attenuates acutes and chronic pain, and suppresses mechanical and thermal hypersensitivity and inhibits nociceptive neuron excitability via up-regulation of its target gene, 1/March/2017, 10.56 pm
March 1, 2018
Show all

National Science day special

*********

We wish everyone a very happy national science day. On this special occasion, we are happy to announce that Bio-Med/Pharma ideas posted today (28/February/2018) will be available to the use of Scientists/Professors/Teachers/Physicians/Researchers for free. So, there will be no terms and conditions for the ideas posted today. Each idea posted will be served first come, first serve basis. Write to admin@genomediscovery.org for more details.

Dr L Boominathan PhD

President, Director & CSO, GBMD.

___________________________________________________________________________________________________________________________

 

What we say:

Dr L Boominathan PhD, Director-cum-chief Scientist of GBMD, reports that:  Combinatorial therapy for Deafness: A therapeutic mix encompassing Spermidine, Cholecalciferol, Ajoene and DIM (SCAD) increases the expression of ATG5 (Autophagy-related 5), prevents aggregation of proteins in inclusion bodies, inhibits hair cell degeneration,  improves hearing loss via up regulation of its target genes

[easy_payment currency=”USD”]


From Significance of the study to Public health relevance:

Given that: (1) more than one seventh of the global population suffers from hearing impairment;  (2) majority of hearing impairment occurs in  low and middle income countries, for instance, 3 in 1000 from developed countries, while 6 in 1000 from developing countries suffer from hearing impairment; (3) damage to the auditory hair cells (HCs) is the principal reason for hearing loss;  (4) only in 50% cases hearing impairment can be cured; and (5) the global annual economic cost spent for unaddressed hearing loss is estimated to be in the range of $750–790 billions, there is an urgent need to find: (i) a way to promote regeneration, growth and proliferation of auditory hair cells  in mammalian cochlea; (ii) a cheaper alternative to the existing expensive drugs; (iii) a side-effect-free natural product-based drug; and (iv) a way to cure, not just treat, hearing impairment.


From research findings to Therapeutic opportunity: 

This study provides, for the first time, mechanistic insights into how a pharmaceutical mixture encompassing Spermidine, Cholecalciferol, Ajoene and DIM (SCAD) may aid in the treatment of hearing impairment.

SCAD, by increasing the expression of its target genes, it may increase the expression of ATG5 (Autophagy-related protein 5). Thereby, it may: (1) prevent degeneration of adult hair cells; (2) prevent aggregation of polyubiquitinated proteins and p62/SQSTM1 in inclusion bodies; (3) promote maintenance of hair cells morphology and hearing acuity; and (4) prevent hearing loss. Thus, pharmacological mixture encompassing “Spermidine, Cholecalciferol, Ajoene and DIM (SCAD) or their analogues, either alone or in combination with other drugs, may be used to treat deafness (Fig.1).

Figure 1 Mechanistic insights into how a therapeutic mix encompassing Spermidine, Cholecalciferol, Ajoene and DIM (SCAD) aids in improving hearing impairment. SCAD prevents aggregation of proteins, promotes regeneration of adult hair cells and inhibits hearing impairment via up-regulation of its target gene ATG5

Figure 2. The chemical structure of Spermidine

[easy_payment currency=”USD”]


Details of the research findings:

Idea Proposed/Formulated (with experimental evidence) by: Dr L Boominathan Ph.D.

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

Undisclosed mechanistic information: How does a therapeutic mix encompassing Spermidine, Cholecalciferol, Ajoene and DIM (SCAD) increase the expression of ATG5?

Amount: $500#

For payment and purchase details, you may reach us at admin@genomediscovery.org

# Research cooperation


References:

Web: http://genomediscovery.org or http://newbioideas.com/

Citation: Boominathan, L., Combinatorial therapy for Deafness: A therapeutic mix encompassing Spermidine, Cholecalciferol, Ajoene and DIM (SCAD) increases the expression of ATG5 (Autophagy-related 5), prevents aggregation of proteins in inclusion bodies, inhibits hair cell degeneration,  improves hearing loss via up regulation of its target genes, 28/February/2018, 11.56 pm, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Courtesy: When you cite, drop us a line at admin@genomediscovery.org

Comments are closed.